Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P et al. (2026)
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease
Eur Respir J, 67 (1)
DOI 10.1183/13993003.02533-2024, PubMed 40907995

Bendstrup E, Dieude P, Kreuter M, Hoffmann-Vold AM, Cottin V, Hauge EM (2026)
Lung disease in rheumatoid arthritis
Nat Rev Rheumatol (in press)
DOI 10.1038/s41584-026-01394-2, PubMed 42315602

Burja B, Boubaya M, Bruni C, Christ L, Ananyeva LP, Atzeni F, Bergmann C, Carreira PE, De Vries-Bouwstra J, Papa ND, Marcoccia A, Masado O, Riemekasten G, Rosato E, Schmeiser T, Sprecher M, Hoffmann-Vold AM, Kollert F, Guler S, Distler O, Elhai M, EUSTAR collaborators (2026)
Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database
Eur J Intern Med, 106898 (in press)
DOI 10.1016/j.ejim.2026.106898, PubMed 42191555